Shuhong Ma

495 total citations
23 papers, 278 citations indexed

About

Shuhong Ma is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Shuhong Ma has authored 23 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Shuhong Ma's work include Pluripotent Stem Cells Research (9 papers), CRISPR and Genetic Engineering (7 papers) and Cardiomyopathy and Myosin Studies (6 papers). Shuhong Ma is often cited by papers focused on Pluripotent Stem Cells Research (9 papers), CRISPR and Genetic Engineering (7 papers) and Cardiomyopathy and Myosin Studies (6 papers). Shuhong Ma collaborates with scholars based in China, South Korea and Japan. Shuhong Ma's co-authors include Feng Lan, Hongjia Zhang, Yun Chang, Siyao Zhang, Fujian Wu, Rui Bai, Tao Dong, Xujie Liu, Bingqian Zhang and Zhiping Peng and has published in prestigious journals such as Circulation Research, Cell Death and Disease and Oncotarget.

In The Last Decade

Shuhong Ma

21 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuhong Ma China 9 157 87 50 45 33 23 278
Anca Chiriac United States 10 187 1.2× 104 1.2× 86 1.7× 23 0.5× 36 1.1× 26 325
Anna Forslöw Sweden 10 146 0.9× 31 0.4× 62 1.2× 36 0.8× 34 1.0× 10 329
Baofeng Yang China 7 150 1.0× 37 0.4× 46 0.9× 21 0.5× 71 2.2× 19 277
Megan Monsanto United States 11 278 1.8× 80 0.9× 170 3.4× 33 0.7× 20 0.6× 15 397
Mona Malek Mohammadi Germany 9 215 1.4× 99 1.1× 78 1.6× 32 0.7× 33 1.0× 14 348
Maribel Marquez United States 8 185 1.2× 29 0.3× 42 0.8× 24 0.5× 19 0.6× 9 300
Anthony C. Sturzu United States 8 273 1.7× 76 0.9× 116 2.3× 18 0.4× 18 0.5× 8 349
Francisco X. Galdos United States 8 181 1.2× 90 1.0× 69 1.4× 73 1.6× 19 0.6× 13 330
Charles P. Rabolli United States 8 176 1.1× 128 1.5× 63 1.3× 13 0.3× 39 1.2× 17 342
Carley Glass United States 9 250 1.6× 97 1.1× 124 2.5× 17 0.4× 102 3.1× 10 362

Countries citing papers authored by Shuhong Ma

Since Specialization
Citations

This map shows the geographic impact of Shuhong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuhong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuhong Ma more than expected).

Fields of papers citing papers by Shuhong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuhong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuhong Ma. The network helps show where Shuhong Ma may publish in the future.

Co-authorship network of co-authors of Shuhong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shuhong Ma. A scholar is included among the top collaborators of Shuhong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuhong Ma. Shuhong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yongshuai, et al.. (2025). Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling. Stem Cell Reviews and Reports. 21(5). 1512–1522.
2.
Zhang, Siyao, et al.. (2025). Metabolism-related gene PDK1 regulates myocardial cell remodeling and its mechanism. Stem Cell Research & Therapy. 16(1). 404–404.
3.
Guo, Tianwei, Hongyue Wang, Fujian Wu, et al.. (2025). Functional analysis of JPH2-knockout cardiomyocytes identifies ECCD as a novel indicator in a human cardiac modelJPH2. Stem Cell Research & Therapy. 16(1). 234–234. 1 indexed citations
4.
Chang, Yun, Feng Lan, Yongshuai Zhang, & Shuhong Ma. (2024). Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling. Stem Cell Reviews and Reports. 20(5). 1151–1161. 1 indexed citations
5.
6.
Tian, Lei, Tianwei Guo, Fujian Wu, et al.. (2023). The pseudoenzyme ADPRHL1 affects cardiac function by regulating the ROCK pathway. Stem Cell Research & Therapy. 14(1). 309–309. 1 indexed citations
7.
Ma, Shuhong, et al.. (2023). The Efficacy of Morodan in Combination with Rabeprazole for the Treatment of Chronic Gastritis and its Impact on Gastric Mucosal Repair.. PubMed. 29(6). 306–310. 1 indexed citations
8.
Li, Hongxia, Shuhong Ma, Min Zhu, et al.. (2022). Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity. Cell Death Discovery. 8(1). 134–134. 6 indexed citations
9.
Ma, Shuhong, et al.. (2022). Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system. Stem Cell Research. 59. 102652–102652. 2 indexed citations
10.
Li, Xiaowei, Tianwei Guo, Wenjing Lu, et al.. (2022). Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 17(4). 804–819. 10 indexed citations
11.
Ma, Shuhong, Fang Li, Miaomiao Xu, et al.. (2022). Chemically defined and small molecules-based generation of sinoatrial node-like cells. Stem Cell Research & Therapy. 13(1). 158–158. 9 indexed citations
12.
Guo, Tianwei, Shuhong Ma, Yun Chang, et al.. (2021). Generation of a homozygous MYH7 gene knockout human embryonic stem cell line (WAe009-A-69) using an episomal vector-based CRISPR/Cas9 system. Stem Cell Research. 57. 102566–102566. 2 indexed citations
13.
Chang, Yun, Yanan Li, Rui Bai, et al.. (2021). hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation. Stem Cell Research & Therapy. 12(1). 278–278. 11 indexed citations
14.
Ma, Shuhong, Qi Xu, Rui Bai, et al.. (2021). Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing. Stem Cell Research. 55. 102470–102470. 3 indexed citations
15.
16.
Guo, Rui, Feng Wan, Masatoshi Morimatsu, et al.. (2021). Cell sheet formation enhances the therapeutic effects of human umbilical cord mesenchymal stem cells on myocardial infarction as a bioactive material. Bioactive Materials. 6(9). 2999–3012. 54 indexed citations
17.
Dong, Tao, Siyao Zhang, Yun Chang, et al.. (2021). The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system. Stem Cell Research. 51. 102196–102196. 3 indexed citations
18.
Li, Yanan, Yun Chang, Xiaolei Li, et al.. (2020). RAD-Deficient Human Cardiomyocytes Develop Hypertrophic Cardiomyopathy Phenotypes Due to Calcium Dysregulation. Frontiers in Cell and Developmental Biology. 8. 585879–585879. 12 indexed citations
19.
Li, Xiaowei, Wenjing Lu, Yanan Li, et al.. (2019). MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling. Cell Death and Disease. 10(8). 610–610. 43 indexed citations
20.
Wang, Yuanyuan, Chengwu Huang, Shuhong Ma, et al.. (2019). Pulse Wave Imaging for Assessing Arterial Stiffness Change in A Mouse Model of Thoracic Aortic Dissection in Marfan Syndrome. 28. 2206–2209. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anca Chiriac Breakdown of academic impact, for papers by Anna Forslöw Breakdown of academic impact, for papers by Baofeng Yang Breakdown of academic impact, for papers by Megan Monsanto Breakdown of academic impact, for papers by Mona Malek Mohammadi Breakdown of academic impact, for papers by Maribel Marquez Breakdown of academic impact, for papers by Anthony C. Sturzu Breakdown of academic impact, for papers by Francisco X. Galdos Breakdown of academic impact, for papers by Charles P. Rabolli Breakdown of academic impact, for papers by Carley Glass
Rankless by CCL
2026